Elotuzumab and dexamethasone for relapsed or refractory multiple myeloma patients: A retrospective study
Sign Up to like & getrecommendations! Published in 2018 at "European Journal of Haematology"
DOI: 10.1111/ejh.13058
Abstract: OBJECTIVE To evaluate the efficacy and safety of elotuzumab and dexamethasone (Ed) for relapsed or refractory multiple myeloma (RRMM) patients. METHOD This retrospective study evaluated the efficacy and safety of Ed treatment for 21 RRMM… read more here.
Keywords: relapsed refractory; dexamethasone relapsed; refractory multiple; multiple myeloma ... See more keywords